American Renal Associates Stock Price, News & Analysis (NYSE:ARA)

$19.88 +0.30 (+1.53 %)
(As of 02/20/2018 02:07 PM ET)
Previous Close$19.58
Today's Range$19.57 - $19.97
52-Week Range$9.91 - $23.30
Volume61,524 shs
Average Volume111,325 shs
Market Capitalization$616 million
P/E Ratio-60.00
Dividend YieldN/A
Beta3.55

About American Renal Associates (NYSE:ARA)

American Renal Associates logoAmerican Renal Associates Holdings, Inc. is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia. The Company operates its dialysis clinics exclusively through a JV model, in which it partners primarily with local nephrologists to develop, own and operate dialysis clinics, while the providers of the majority of dialysis services in the United States operate through a combination of subsidiaries and joint ventures. It provides patient care and clinical outcomes to patients suffering from end-stage renal disease (ESRD). Its clinics offer both in center and home dialysis options to meet the needs of patients. Its clinics primarily provide in center hemodialysis treatments and ancillary items and services.

Receive ARA News and Ratings via Email

Sign-up to receive the latest news and ratings for ARA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryN/A
SectorMedical
SymbolNYSE:ARA
CUSIPN/A
Phone978-922-3080

Debt

Debt-to-Equity Ratio3.57%
Current Ratio1.16%
Quick Ratio1.13%

Price-To-Earnings

Trailing P/E Ratio-59.9981818732766
Forward P/E Ratio35.50
P/E Growth1.35

Sales & Book Value

Annual Sales$749.77 million
Price / Sales0.83
Cash Flow$2.18 per share
Price / Cash9.12
Book Value$4.72 per share
Price / Book4.21

Profitability

Trailing EPS($0.33)
Net Income$-380,000.00
Net Margins-2.15%
Return on Equity15.80%
Return on Assets2.34%

Miscellaneous

Employees4,601
Outstanding Shares31,460,000

American Renal Associates (NYSE:ARA) Frequently Asked Questions

What is American Renal Associates' stock symbol?

American Renal Associates trades on the New York Stock Exchange (NYSE) under the ticker symbol "ARA."

How were American Renal Associates' earnings last quarter?

American Renal Associates Holdings Inc (NYSE:ARA) posted its quarterly earnings results on Tuesday, November, 14th. The company reported $0.19 EPS for the quarter, beating the Zacks' consensus estimate of $0.16 by $0.03. The business had revenue of $187.71 million for the quarter, compared to analysts' expectations of $194.60 million. American Renal Associates had a positive return on equity of 15.80% and a negative net margin of 2.15%. The business's quarterly revenue was down 2.7% on a year-over-year basis. During the same period last year, the firm earned $0.28 earnings per share. View American Renal Associates' Earnings History.

When will American Renal Associates make its next earnings announcement?

American Renal Associates is scheduled to release their next quarterly earnings announcement on Monday, March, 5th 2018. View Earnings Estimates for American Renal Associates.

Where is American Renal Associates' stock going? Where will American Renal Associates' stock price be in 2018?

4 analysts have issued 12-month target prices for American Renal Associates' stock. Their forecasts range from $17.00 to $23.00. On average, they expect American Renal Associates' stock price to reach $20.00 in the next year. View Analyst Ratings for American Renal Associates.

Who are some of American Renal Associates' key competitors?

Who are American Renal Associates' key executives?

American Renal Associates' management team includes the folowing people:

  • Joseph A. Carlucci, Chairman of the Board, Chief Executive Officer, Co-Founder (Age 63)
  • Syed T. Kamal, President, Co-Founder, Director (Age 64)
  • Jonathan L. Wilcox, Chief Financial Officer, Vice President (Age 43)
  • Don Williamson, Chief Operating Officer, Executive Vice President (Age 54)
  • Jason M. Boucher, Chief Accounting Officer, Vice President - Finance, Treasurer (Age 45)
  • Michael R. Costa Esq., Vice President, General Counsel, Secretary (Age 46)
  • Michael E. Boxer, Independent Director (Age 55)
  • Susanne V. Clark, Independent Director (Age 48)
  • Thomas W. Erickson, Independent Director (Age 66)
  • Robert H. Fish, Independent Director (Age 66)

When did American Renal Associates IPO?

(ARA) raised $161 million in an initial public offering (IPO) on Thursday, April 21st 2016. The company issued 7,500,000 shares at a price of $20.00-$23.00 per share. BofA Merrill Lynch, Barclays and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who owns American Renal Associates stock?

American Renal Associates' stock is owned by many different of institutional and retail investors. Top institutional shareholders include TimesSquare Capital Management LLC (3.35%), Franklin Resources Inc. (2.38%), AMI Asset Management Corp (2.18%), BlackRock Inc. (2.01%), Acadian Asset Management LLC (0.66%) and Millennium Management LLC (0.61%). Company insiders that own American Renal Associates stock include Jason Allen Ross Brewster, John J Mcdonough, Jonathan L Wilcox and Michael Ray Costa. View Institutional Ownership Trends for American Renal Associates.

Who sold American Renal Associates stock? Who is selling American Renal Associates stock?

American Renal Associates' stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., TimesSquare Capital Management LLC, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, AMI Asset Management Corp, Schwab Charles Investment Management Inc., Endurant Capital Management LP, Franklin Resources Inc. and Wells Fargo & Company MN. View Insider Buying and Selling for American Renal Associates.

Who bought American Renal Associates stock? Who is buying American Renal Associates stock?

American Renal Associates' stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Acadian Asset Management LLC, TIAA CREF Investment Management LLC, Cornercap Investment Counsel Inc., Citadel Advisors LLC, Alambic Investment Management L.P., BlackRock Inc. and Schroder Investment Management Group. Company insiders that have bought American Renal Associates stock in the last two years include Jason Allen Ross Brewster, John J Mcdonough, Jonathan L Wilcox and Michael Ray Costa. View Insider Buying and Selling for American Renal Associates.

How do I buy American Renal Associates stock?

Shares of American Renal Associates can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is American Renal Associates' stock price today?

One share of American Renal Associates stock can currently be purchased for approximately $19.88.

How big of a company is American Renal Associates?

American Renal Associates has a market capitalization of $616 million and generates $749.77 million in revenue each year. The company earns $-380,000.00 in net income (profit) each year or ($0.33) on an earnings per share basis. American Renal Associates employs 4,601 workers across the globe.

How can I contact American Renal Associates?

American Renal Associates' mailing address is 500 CUMMINGS CENTER SUITE 6550, BEVERLY MA, 01915. The company can be reached via phone at 978-922-3080 or via email at [email protected]


MarketBeat Community Rating for American Renal Associates (ARA)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  101 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  194
MarketBeat's community ratings are surveys of what our community members think about American Renal Associates and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

American Renal Associates (NYSE:ARA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.50
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $20.00$20.00$19.33$23.50
Price Target Upside: 19.05% upside19.05% upside51.52% upside36.00% upside

American Renal Associates (NYSE:ARA) Consensus Price Target History

Price Target History for American Renal Associates (NYSE:ARA)

American Renal Associates (NYSE:ARA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/21/2017SunTrust BanksSet Price TargetBuy$20.00MediumView Rating Details
11/21/2017Leerink SwannReiterated RatingOutperform$22.00 -> $17.00N/AView Rating Details
5/11/2017Wells Fargo & CoUpgradeMarket Perform -> OutperformHighView Rating Details
3/9/2017BarclaysLower Price TargetOverweight$25.00 -> $23.00LowView Rating Details
11/21/2016Goldman Sachs GroupDowngradeNeutral -> SellN/AView Rating Details
8/22/2016Bank of AmericaReiterated RatingBuy$35.00N/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

American Renal Associates (NYSE:ARA) Earnings History and Estimates Chart

Earnings by Quarter for American Renal Associates (NYSE:ARA)

American Renal Associates (NYSE ARA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/5/2018$0.16N/AView Earnings Details
11/14/2017Q3 2017$0.16$0.19$194.60 million$187.71 millionViewN/AView Earnings Details
8/8/2017Q2 2017$0.12$0.16$188.23 million$185.99 millionViewListenView Earnings Details
5/9/2017Q1 2017$0.10$0.06$184.67 million$177.00 millionViewListenView Earnings Details
3/7/2017Q4 2016$0.28$0.26$197.84 million$199.11 millionViewListenView Earnings Details
11/10/2016Q316$0.24$0.28$189.73 million$192.96 millionViewN/AView Earnings Details
8/9/2016Q2 2016$0.22$0.26$178.14 million$186.94 millionViewN/AView Earnings Details
5/12/2016Q116$0.16$149.30 million$172.10 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

American Renal Associates (NYSE:ARA) Earnings Estimates

2018 EPS Consensus Estimate: $0.69
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.10$0.10$0.10
Q2 20181$0.18$0.18$0.18
Q3 20181$0.19$0.19$0.19
Q4 20181$0.22$0.22$0.22
Q1 20191$0.15$0.15$0.15
Q2 20191$0.21$0.21$0.21
Q3 20191$0.23$0.23$0.23
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for American Renal Associates (NYSE:ARA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

American Renal Associates (NYSE ARA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 12.62%
Institutional Ownership Percentage: 91.38%
Insider Trades by Quarter for American Renal Associates (NYSE:ARA)
Insider Trades by Quarter for American Renal Associates (NYSE:ARA)

American Renal Associates (NYSE ARA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/9/2017Jason Allen Ross BrewsterDirectorBuy80,000$0.03$2,400.00
4/26/2016John J McdonoughCOOBuy1,000$22.00$22,000.00262,967View SEC Filing  
4/26/2016Jonathan L WilcoxCFOBuy500$22.00$11,000.003,771View SEC Filing  
4/26/2016Michael Ray CostaVPBuy370$22.00$8,140.00View SEC Filing  
4/2/2015Meyer (Mike) Frederi FlorenceDirectorBuy12,000$0.01$120.00
(Data available from 1/1/2013 forward)

Headlines

American Renal Associates (NYSE ARA) News Headlines

Source:
DateHeadline
 Analysts Expect American Renal Associates Holdings Inc (ARA) Will Announce Quarterly Sales of $196.25 Million Analysts Expect American Renal Associates Holdings Inc (ARA) Will Announce Quarterly Sales of $196.25 Million
www.americanbankingnews.com - February 16 at 1:04 PM
Zacks: Brokerages Anticipate American Renal Associates Holdings Inc (ARA) to Announce $0.15 Earnings Per ShareZacks: Brokerages Anticipate American Renal Associates Holdings Inc (ARA) to Announce $0.15 Earnings Per Share
www.americanbankingnews.com - February 14 at 1:08 AM
Investor Expectations to Drive Momentum within A. O. Smith, Jacobs Engineering Group, Ligand Pharmaceuticals, National CineMedia, American Renal Associates, and Acco Brands — Discovering Underlying Factors of InfluenceInvestor Expectations to Drive Momentum within A. O. Smith, Jacobs Engineering Group, Ligand Pharmaceuticals, National CineMedia, American Renal Associates, and Acco Brands — Discovering Underlying Factors of Influence
finance.yahoo.com - February 12 at 8:56 AM
American Renal Associates (ARA) vs. Cancer Genetics (CGIX) Financial AnalysisAmerican Renal Associates (ARA) vs. Cancer Genetics (CGIX) Financial Analysis
www.americanbankingnews.com - February 9 at 9:10 PM
Critical Contrast: American Renal Associates (ARA) vs. MEDNAX (MD)Critical Contrast: American Renal Associates (ARA) vs. MEDNAX (MD)
www.americanbankingnews.com - February 6 at 9:14 AM
BRIEF-American Renal Associates Settles Shareholder Class Action LitigationBRIEF-American Renal Associates Settles Shareholder Class Action Litigation
www.reuters.com - February 2 at 8:59 AM
American Renal Associates Holdings, Inc. Announces Settlement of Shareholder Class Action LitigationAmerican Renal Associates Holdings, Inc. Announces Settlement of Shareholder Class Action Litigation
finance.yahoo.com - February 1 at 9:04 AM
American Renal Associates (ARA) Lowered to Sell at Zacks Investment ResearchAmerican Renal Associates (ARA) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - January 23 at 5:28 PM
Reviewing Acadia Healthcare (ACHC) & American Renal Associates (ARA)Reviewing Acadia Healthcare (ACHC) & American Renal Associates (ARA)
www.americanbankingnews.com - January 23 at 3:24 AM
American Renal Associates Holdings Inc (ARA) Expected to Announce Quarterly Sales of $196.25 MillionAmerican Renal Associates Holdings Inc (ARA) Expected to Announce Quarterly Sales of $196.25 Million
www.americanbankingnews.com - January 13 at 2:36 PM
 Brokerages Anticipate American Renal Associates Holdings Inc (ARA) to Post $0.15 EPS Brokerages Anticipate American Renal Associates Holdings Inc (ARA) to Post $0.15 EPS
www.americanbankingnews.com - January 11 at 1:38 AM
Reviewing Kindred Healthcare (KND) & American Renal Associates (ARA)Reviewing Kindred Healthcare (KND) & American Renal Associates (ARA)
www.americanbankingnews.com - January 4 at 7:32 PM
Comparing Kindred Healthcare (KND) & American Renal Associates (ARA)Comparing Kindred Healthcare (KND) & American Renal Associates (ARA)
www.americanbankingnews.com - December 30 at 1:26 AM
American Renal Associates Holdings Inc (ARA) Expected to Announce Earnings of $0.15 Per ShareAmerican Renal Associates Holdings Inc (ARA) Expected to Announce Earnings of $0.15 Per Share
www.americanbankingnews.com - December 25 at 1:16 PM
SunTrust Banks Comments on American Renal Associates Holdings Incs Q2 2018 Earnings (ARA)SunTrust Banks Comments on American Renal Associates Holdings Inc's Q2 2018 Earnings (ARA)
www.americanbankingnews.com - December 22 at 1:28 PM
American Renal Associates (ARA) PT Set at $20.00 by SunTrust BanksAmerican Renal Associates (ARA) PT Set at $20.00 by SunTrust Banks
www.americanbankingnews.com - December 22 at 7:16 AM
SunTrust Banks Research Analysts Decrease Earnings Estimates for American Renal Associates Holdings Inc (ARA)SunTrust Banks Research Analysts Decrease Earnings Estimates for American Renal Associates Holdings Inc (ARA)
www.americanbankingnews.com - December 21 at 9:16 AM
Head to Head Analysis: American Renal Associates (ARA) and Surgical Care Affiliates (SCAI)Head to Head Analysis: American Renal Associates (ARA) and Surgical Care Affiliates (SCAI)
www.americanbankingnews.com - December 17 at 11:32 AM
ETFs with exposure to American Renal Associates Holdings, Inc. : December 13, 2017ETFs with exposure to American Renal Associates Holdings, Inc. : December 13, 2017
finance.yahoo.com - December 13 at 4:04 PM
American Renal Associates Holdings, Inc. :ARA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 12, 2017American Renal Associates Holdings, Inc. :ARA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 12, 2017
finance.yahoo.com - December 12 at 11:41 AM
Zacks: Brokerages Anticipate American Renal Associates Holdings Inc (ARA) Will Announce Earnings of $0.16 Per ShareZacks: Brokerages Anticipate American Renal Associates Holdings Inc (ARA) Will Announce Earnings of $0.16 Per Share
www.americanbankingnews.com - December 7 at 9:36 PM
American Renal Associates Holdings, Inc. – Value Analysis (NYSE:ARA) : November 28, 2017American Renal Associates Holdings, Inc. – Value Analysis (NYSE:ARA) : November 28, 2017
finance.yahoo.com - November 28 at 3:54 PM
American Renal Associates Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ARA-US : November 27, 2017American Renal Associates Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ARA-US : November 27, 2017
finance.yahoo.com - November 27 at 12:55 PM
American Renal Associates Holdings, Inc (ARA) Expected to Post Quarterly Sales of $200.75 MillionAmerican Renal Associates Holdings, Inc (ARA) Expected to Post Quarterly Sales of $200.75 Million
www.americanbankingnews.com - November 22 at 12:00 PM
American Renal Associates Holdings, Inc Forecasted to Earn FY2017 Earnings of $0.59 Per Share (ARA)American Renal Associates Holdings, Inc Forecasted to Earn FY2017 Earnings of $0.59 Per Share (ARA)
www.americanbankingnews.com - November 22 at 6:46 AM
American Renal Associates Holdings, Inc (ARA) Rating Reiterated by Leerink SwannAmerican Renal Associates Holdings, Inc (ARA) Rating Reiterated by Leerink Swann
www.americanbankingnews.com - November 21 at 9:18 AM
Robbins Arroyo LLP Is Investigating the Officers and Directors of American Renal Associates Holdings, Inc. (ARA) on Behalf of ShareholdersRobbins Arroyo LLP Is Investigating the Officers and Directors of American Renal Associates Holdings, Inc. (ARA) on Behalf of Shareholders
finance.yahoo.com - November 20 at 10:26 PM
$0.15 Earnings Per Share Expected for American Renal Associates Holdings, Inc (ARA) This Quarter$0.15 Earnings Per Share Expected for American Renal Associates Holdings, Inc (ARA) This Quarter
www.americanbankingnews.com - November 20 at 1:28 AM
Edited Transcript of ARA earnings conference call or presentation 15-Nov-17 2:00pm GMTEdited Transcript of ARA earnings conference call or presentation 15-Nov-17 2:00pm GMT
finance.yahoo.com - November 19 at 2:03 AM
American Renal Associates Holdings, Inc Forecasted to Earn FY2017 Earnings of $0.57 Per Share (ARA)American Renal Associates Holdings, Inc Forecasted to Earn FY2017 Earnings of $0.57 Per Share (ARA)
www.americanbankingnews.com - November 17 at 9:44 PM
American Renal Associates Holdings, Inc (ARA) Lowered to "Hold" at Zacks Investment ResearchAmerican Renal Associates Holdings, Inc (ARA) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - November 17 at 7:58 PM
American Renal Associates Holdings, Inc (ARA) Raised to Buy at Zacks Investment ResearchAmerican Renal Associates Holdings, Inc (ARA) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - November 16 at 5:32 PM
American Renal Associates (ARA) CEO Joe Carlucci on Q3 2017 Results - Earnings Call TranscriptAmerican Renal Associates' (ARA) CEO Joe Carlucci on Q3 2017 Results - Earnings Call Transcript
www.msn.com - November 16 at 4:16 PM
ETFs with exposure to American Renal Associates Holdings, Inc. : November 15, 2017ETFs with exposure to American Renal Associates Holdings, Inc. : November 15, 2017
finance.yahoo.com - November 16 at 11:22 AM
American Renal Associates Holdings, Inc (ARA) Announces  Earnings ResultsAmerican Renal Associates Holdings, Inc (ARA) Announces Earnings Results
www.americanbankingnews.com - November 15 at 10:34 AM
Kynikos Chanos says hes betting against dialysis companiesKynikos' Chanos says he's betting against dialysis companies
www.nasdaq.com - November 14 at 9:31 PM
Can American Renal Associates Holdings Inc’s (ARA) ROE Continue To Surpass The Industry Average?Can American Renal Associates Holdings Inc’s (ARA) ROE Continue To Surpass The Industry Average?
finance.yahoo.com - November 14 at 4:29 PM
American Renal Associates Holdings, Inc. Announces Third Quarter 2017 ResultsAmerican Renal Associates Holdings, Inc. Announces Third Quarter 2017 Results
finance.yahoo.com - November 14 at 4:29 PM
American Renal Associates Holdings Enters Oversold TerritoryAmerican Renal Associates Holdings Enters Oversold Territory
www.thestreet.com - November 2 at 4:33 PM
American Renal Associates Holdings, Inc (ARA) Scheduled to Post Quarterly Earnings on WednesdayAmerican Renal Associates Holdings, Inc (ARA) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - November 1 at 4:08 AM
American Renal Associates Holdings, Inc. Announces Third Quarter 2017 Earnings Release Date and Conference CallAmerican Renal Associates Holdings, Inc. Announces Third Quarter 2017 Earnings Release Date and Conference Call
finance.yahoo.com - October 31 at 5:15 PM
American Renal Associates Holdings Inc (ARA) Expected to Announce Earnings of $0.16 Per ShareAmerican Renal Associates Holdings Inc (ARA) Expected to Announce Earnings of $0.16 Per Share
www.americanbankingnews.com - October 30 at 1:24 PM
ETFs with exposure to American Renal Associates Holdings, Inc. : October 27, 2017ETFs with exposure to American Renal Associates Holdings, Inc. : October 27, 2017
finance.yahoo.com - October 27 at 3:40 PM
Short Interest Declines 11.3% For ARAShort Interest Declines 11.3% For ARA
www.thestreet.com - October 25 at 5:08 PM
American Renal Associates Holdings, Inc (ARA) Expected to Post Quarterly Sales of $196.15 MillionAmerican Renal Associates Holdings, Inc (ARA) Expected to Post Quarterly Sales of $196.15 Million
www.americanbankingnews.com - October 13 at 9:32 AM
Financial Comparison: American Renal Associates Holdings (ARA) and Community Health Systems (CYH)Financial Comparison: American Renal Associates Holdings (ARA) and Community Health Systems (CYH)
www.americanbankingnews.com - October 10 at 10:32 AM
ETFs with exposure to American Renal Associates Holdings, Inc. : October 6, 2017ETFs with exposure to American Renal Associates Holdings, Inc. : October 6, 2017
finance.yahoo.com - October 6 at 4:15 PM
American Renal Associates Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ARA-US : October 3, 2017American Renal Associates Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ARA-US : October 3, 2017
finance.yahoo.com - October 3 at 3:46 PM
Comparing American Renal Associates Holdings (ARA) and Select Medical Holdings Corporation (SEM)Comparing American Renal Associates Holdings (ARA) and Select Medical Holdings Corporation (SEM)
www.americanbankingnews.com - September 27 at 6:22 AM
Critical Review: American Renal Associates Holdings (ARA) vs. The CompetitionCritical Review: American Renal Associates Holdings (ARA) vs. The Competition
www.americanbankingnews.com - September 26 at 8:12 AM

SEC Filings

American Renal Associates (NYSE:ARA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

American Renal Associates (NYSE:ARA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

American Renal Associates (NYSE ARA) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.